Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Zhang J, Maimaiti A, Chang X, Sun P, Chang X
Cell Death Dis. 2024; 15(11):849.
PMID: 39567474
PMC: 11579010.
DOI: 10.1038/s41419-024-07212-5.
Jin Z, Guo T, Zhang X, Wang X, Liu Y
Front Oncol. 2024; 14:1448695.
PMID: 39474113
PMC: 11518688.
DOI: 10.3389/fonc.2024.1448695.
Saadan N, Ahmed W, Kadi A, Al-Mutairi M, Al-Wabli R, Rahman A
ACS Omega. 2024; 9(40):41944-41967.
PMID: 39398118
PMC: 11465279.
DOI: 10.1021/acsomega.4c06889.
Abramczyk H, Surmacki J, Kopec M
J Med Chem. 2024; 67(19):17629-17639.
PMID: 39305290
PMC: 11472312.
DOI: 10.1021/acs.jmedchem.4c01591.
Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect.
Chompunud Na Ayudhya C, Graidist P, Tipmanee V
Sci Rep. 2024; 14(1):12531.
PMID: 38822100
PMC: 11143223.
DOI: 10.1038/s41598-024-63505-x.
Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient.
Schaffrin-Nabe D, Josten-Nabe A, Tannapfel A, Uhl W, Garmer M, Kurzrock R
Front Oncol. 2024; 14:1395618.
PMID: 38764581
PMC: 11099277.
DOI: 10.3389/fonc.2024.1395618.
Receptor tyrosine kinases: biological functions and anticancer targeted therapy.
Zhang N, Li Y
MedComm (2020). 2023; 4(6):e446.
PMID: 38077251
PMC: 10701465.
DOI: 10.1002/mco2.446.
Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling.
Murugesan A, Konda Mani S, Thiyagarajan R, Palanivel S, Gurbanov A, Zubkov F
Int J Mol Sci. 2023; 24(15).
PMID: 37569654
PMC: 10418358.
DOI: 10.3390/ijms241512276.
An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma.
Rodriguez S, Kamel A, Ciubotaru G, Onose G, Sevastre A, Sfredel V
Int J Mol Sci. 2023; 24(13).
PMID: 37446288
PMC: 10341823.
DOI: 10.3390/ijms241311110.
Crystal structure of the kinase domain of a receptor tyrosine kinase from a choanoflagellate, Monosiga brevicollis.
Bajaj T, Kuriyan J, Gee C
PLoS One. 2023; 18(6):e0276413.
PMID: 37310965
PMC: 10263333.
DOI: 10.1371/journal.pone.0276413.
Role of Molecular Targeted Therapeutic Drugs in Treatment of Glioblastoma: A Review Article.
Singh H
Glob Med Genet. 2023; 10(2):42-47.
PMID: 37077370
PMC: 10110362.
DOI: 10.1055/s-0043-57028.
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery.
Schulz J, Hartz A, Bauer B
Pharmacol Rev. 2023; 75(5):815-853.
PMID: 36973040
PMC: 10441638.
DOI: 10.1124/pharmrev.120.000025.
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Paillasse M, Esquerre M, Bertrand F, Poussereau-Pomie C, Pichery M, Visentin V
Cancer Res Commun. 2023; 2(11):1504-1519.
PMID: 36970050
PMC: 10035370.
DOI: 10.1158/2767-9764.CRC-22-0151.
Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7.
Liu Q, Li S, Qiu Y, Zhang J, Rios F, Zou Z
Front Cardiovasc Med. 2023; 10:1002438.
PMID: 36818331
PMC: 9936099.
DOI: 10.3389/fcvm.2023.1002438.
Molecular targeted therapy: A new avenue in glioblastoma treatment.
El Atat O, Naser R, Abdelkhalek M, Habib R, El Sibai M
Oncol Lett. 2023; 25(2):46.
PMID: 36644133
PMC: 9811647.
DOI: 10.3892/ol.2022.13632.
Pituitary corticotroph identity and receptor-mediated signaling: a transcriptomics perspective.
Stojilkovic S, Previde R, Sherman A, Fletcher P
Curr Opin Endocr Metab Res. 2022; 25.
PMID: 36177190
PMC: 9514143.
DOI: 10.1016/j.coemr.2022.100364.
Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.
Tang R, Langdon W, Zhang J
Front Endocrinol (Lausanne). 2022; 13:971162.
PMID: 35966060
PMC: 9365936.
DOI: 10.3389/fendo.2022.971162.
Inhibition of Epidermal Growth Factor Receptor Signaling by Antisense Oligonucleotides as a Novel Approach to Epidermal Growth Factor Receptor Inhibition.
Madanayake T, Welsh E, Darville L, Koomen J, Chalfant C, Haura E
Nucleic Acid Ther. 2022; 32(5):391-400.
PMID: 35861718
PMC: 9595651.
DOI: 10.1089/nat.2021.0101.
Elucidating the Focal Immunomodulatory Clues Influencing Mesenchymal Stem Cells in the Milieu of Intervertebral Disc Degeneration.
Hechavarria M, Richard S
Curr Stem Cell Res Ther. 2022; 18(1):62-75.
PMID: 35450531
DOI: 10.2174/1574888X17666220420134619.